Mifepristone protocols being wielded by pill's opponents in Supreme Court case
Cautious protocols adopted 20 years ago by the FDA in its approval of the abortion pill are now being touted as evidence of its dangers.
Source: statnews.com
📰 Risk Evaluation News
Page 6 - Risk Evaluation News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Risk Evaluation. Real-time updates on events, politics, business and more.
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
Generated $397 million in full year 2023 revenues, including $275 million for SYFOVRE® and $91 million for EMPAVELI® Strong SYFOVRE launch, with more than 160,000 total doses distributed in 2023...
United States Lissa Pavluk Cedric Francois Meredith Kaya American Academy Of Ophthalmology Exchange Commission
Source: marketscreener.com
Formaldehyde - Why Manufacturers Should Be Paying Attention | K&L Gates LLP
Companies using formaldehyde in their operations should be aware of recent developments with the potential to substantially impact litigation concerning this substance. With regulations...
United States Alameda County David Koenig Davida Fusco American Airlines National Academy Of Sciences
Source: jdsupra.com
Legend Biotech Announces Positive CHMP Opinion for CARVYKTI® (ciltacabtagene autoleucel) for the Treatment of Patients with Relapsed and Lenalidomide Refractory Multiple Myeloma in Earlier Lines of Therapy
CARVYKTI® is the first CAR-T therapy for patients with relapsed and refractory multiple myeloma to receive a positive CHMP opinion for second line treatment ...
New Jersey United States Ying Huang European Medicines Agency American Society Of Clinical Oncology Drug Administration
Source: marketscreener.com
Legend Biotech Announces Positive CHMP Opinion for CARVYKTI (ciltacabtagene autoleucel) for the Treatment of Patients with Relapsed and Lenalidomide Refractory Multiple Myeloma in Earlier Lines of Therapy
23.02.2024 - Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended expansion of the CARVYKTI ...
New Jersey United States Cancer Center Clinica Universidad De Navarra Cancer Center Clinica Universidad De Navarra Spain European Commission Legend Biotech Corporation Stock
Source: wallstreet-online.de
Wrap-Up of Federal and State Chemical Regulatory Developments, February 2024 | Bergeson & Campbell, P.C.
TSCA/FIFRA/TRI - EPA Announces Automatic Addition Of Seven Additional PFAS To TRI List Of Chemicals: The U.S. Environmental Protection Agency (EPA) announced on January...
United States Bergeson Campbell Marie Gluesenkamp Perez Rob Bonta Michal Freedhoff Shelley Moore Capito
Source: jdsupra.com
TECVAYLI® (teclistamab-cqyv) biweekly dosing approved by the U.S. FDA for the treatment of patients with relapsed or refractory multiple myeloma
/PRNewswire/ -- Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application...
Source: prnewswire.com
The Rise of Due Diligence Legislation and What it Means for Coffee Companies
In the last few years, there has been a dramatic increase in the number and scope of regional, national, and state-level laws focused on human rights due diligence.
United States United Kingdom Nick Brown European Parliament European Union Us Department Of Cooperation On Fair
Source: dailycoffeenews.com
How Carbon Management Can Benefit Your Company's Bottom-Line | J.S. Held
Introduction: Strategic Carbon Management - The corporate world is experiencing significant growth in the need for carbon management services. Within the diverse field of...
France General Steven Andersen Global Reporting Initiative Foundation Of Carbon Management International Energy Agency World Outlook Task Force On Financial Disclosures
Source: jdsupra.com
Availability of Long-Acting Injectable Buprenorphine at Substance Use Treatment Facilities
This study assesses the proportion of US substance use and mental health care facilities that offered any medications for opioid use disorder and, specifically,
Source: jamanetwork.com